In this study, we used a combination of traditional signaling investigation approaches, bioluminescence resonance energy transfer (BRET) biosensors, and the label-free approach surface plasmon resonance (SPR) spectroscopy to monitor the signaling cascades of the m-opioid receptor (MOP). In human embryonic kidney cells stably expressing a Flag-tagged version of human MOP, we compared the signals triggered by the noninternalizing and internalizing MOP agonists morphine and DAMGO (Tyr-DAla-Gly-N-methyl-Phe-Gly-ol), respectively. We studied three major and well described components of MOP signaling: receptor internalization, G protein coupling, and activation of extracellular signal-regulated kinase ERK1/ERK2. Our results show that morphine and DAMGO display different profiles of receptor internalization and a similar ability to trigger the phosphorylation of ERK1/ERK2. Our SPR analyses revealed that morphine and DAMGO evoke similar SPR signatures and that Ga i , cAMP-dependent pathways, and ERK1/ERK2 have key roles in morphine-and DAMGO-mediated signaling. Most interestingly, we found that the so-called MOP neutral antagonists CTOP (D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH 2 ), naloxone, and naltrexone behave like partial agonists. Even more intriguing, BRET experiments indicate that CTAP (D-Phe-CysTyr-D-Trp-Arg-Thr-Pen-Thr-NH 2 ) induces similar conformational changes as naltrexone at the Ga i -bg interface, whereas it appears as an inverse agonist based on its SPR response thus indicating distinct signaling mechanisms for the two ligands. Taken together, our results support the usefulness of labelfree methods such as SPR to study whole-cell responses and signaling cascades triggered by G protein-coupled receptors and complement the conventional approaches by revealing cellular responses that would have been otherwise undetectable.
Introduction
Opioids targeting the m-opioid receptors (MOPs) are still the most powerful analgesics used for the treatment of moderate to severe pain conditions (Melnikova, 2010) . However, the use of MOP agonists is often limited by the occurrence of adverse effects such as constipation and nausea (Cherny et al., 2001) . As a member of the class A G proteincoupled receptors (GPCRs), MOP is coupled to the heterotrimeric G protein Ga i , which leads to the inhibition of the adenylyl cyclase and a decrease in cAMP levels. In addition, the activation of MOP leads to the inhibition of voltage-gated calcium channels and the activation of G protein-coupled inwardly rectifying potassium channels (Williams et al., 2001 ). Several differences have been noted among MOP agonists with regard to the signaling pathways they trigger (Arttamangkul et al., 2008; Zheng et al., 2008; McPherson et al., 2010) , which is consistent with the concept of functional selectivity in which different ligands targeting the same receptor can elicit distinct signaling cascades (Urban et al., 2007) . In this context, the molecular events specifically leading to analgesia and adverse effects have not been thoroughly described. Consequently, a better understanding of these events is required for the development of new opioid drugs with reduced adverse effects (Raehal et al., 2011) .
The assessment of functional selectivity requires the evaluation of global cell responses after the activation of a GPCR. Therefore, a valuable approach to study this phenomenon would be to use a technology capable of detecting any change within the cell induced by the activation of a receptor. Whole-cell biosensors such as impedance-and optical-based detection systems may serve this need (Ciambrone et al., 2004; Cunningham et al., 2004; Fang et al., 2006) . Compared with traditional assays, whole-cell biosensors offer the possibility to globally evaluate multiple aspects of the cell response in a single, highly sensitive assay (Giaever and Keese, 1993; Scott and Peters, 2010) . These approaches do not require fluorescent or radioactive probes, which can affect the functions of some proteins within the cell (Cooper, 2006) . Recent reports demonstrated the usefulness of whole-cell biosensors to study functional selectivity of several GPCRs. For example, Stallaert et al. (2012) used an impedance-based system to assess functional selectivity at the b 2 adrenergic receptor, whereas Morse et al. (2011 Morse et al. ( , 2013 used an optical-based system to assess opioid receptor signaling. We previously showed that SPR represents a valuable label-free technique to monitor GPCR signaling and apoptosis (Cuerrier et al., 2008; Chabot et al., 2009; Maltais et al., 2012) .
In this study, we use SPR as a sensitive label-free technique to assess functional selectivity of MOP signaling in living cells. We hypothesized that distinct signaling pathways triggered by different ligands acting on the same receptor can be assessed by analyzing distinctive SPR signals. We used DAMGO (Tyr-D-Ala-Gly-N-methyl-Phe-Gly-ol) and morphine as selective MOP agonists because they are known to exhibit distinct signaling properties. We also evaluated the contribution of three different MOP signaling components in the SPR responses: receptor internalization, G protein coupling, and activation of extracellular signal-regulated kinase ERK1/ ERK2. We also evaluated the implication of G protein coupling in the SPR responses generated by four MOP ligands previously described as antagonists (Mulder et al., 1991; Janecka et al., 2004) .
Materials and Methods

Cell Culture
Human embryonic kidney (HEK)-293 cells stably expressing Flagtagged human MOP (HEK FlagMOP), with a receptor density of 2.5 pmol/mg cell proteins (Morse et al., 2011) , were kindly provided by Dr. Mark von Zastrow (University of California, San Francisco, CA). The cells were grown at 37°C in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum and 50 mg/l gentamicin in a humidified atmosphere of 95% air and 5% CO 2 . The cells were maintained in a medium containing 250 mg/ml of the selection agent Geneticin (G418).
MOP Internalization Assay
HEK FlagMOP cells were grown on poly(L-lysine)-coated glass coverslips for 2 to 3 days until they reached 60%-70% confluence. Before stimulation, the cells were starved with DMEM for 30 minutes with or without 80 mM dynasore [3-hydroxynaphthalene-2-carboxylic acid-(3,4-dihydroxybenzylidene)-hydrazide; BioVision Incorporated, Milpitas, CA]). The cells were then stimulated with 1 mM DAMGO (Tocris Bioscience, R&D Systems, Minneapolis, MN) or with 1 mM morphine sulfate (Sandoz Canada, Boucherville, Canada). The stimulation was terminated by the aspiration of the culture medium and the addition of ice-cold phosphate-buffered saline (PBS) (140 mM NaCl, 2.7 mM KCl, 8.1 mM Na 2 HPO 4 , and 1.5 mM KH 2 PO 4 ; pH 7.2). The cells were then fixed for 15 minutes with an ice-cold 4% paraformaldehyde solution in PBS. The cells were washed three times with a 0.02% Triton X-100 solution in PBS (PBST), followed by a 10-minute block with a PBST solution containing 2% bovine serum albumin (PBST/BSA). After blocking, the cells were incubated for 2 hours at room temperature with a mouse anti-Flag M1 antibody , and the coverslips were mounted on microscope glass slides with AquaPolymount (Polysciences, Warrington, PA). For each condition, 26-30 cells were imaged using a Fluoview 1000 (FV1000) laser scanning confocal IX81 Olympus microscope (Olympus America, Center Valley, PA) equipped with a ProScan II motorized stage system (Prior Scientific, Rockland, MA) and fitted with a U plan S-Apo 60Â (1.35 numerical aperture) oil-immersion objective. Each micrograph represents an optical slice of 0.31 mm and displays a clear horizontal section of the cell nucleus. Pixel quantification was performed using a custom-built software integrated to ImageJ software (National Institutes of Health, Bethesda, MD). This software allows for the calculation of intracellular and cell membrane pixels. The membrane thickness was fixed at a width of six pixels throughout the analysis of each condition. Pseudo-colors were used to easily distinguish between intracellular (green) and cell membrane (purple) pixels. The results obtained from those analyses were expressed as a ratio of intracellular/cell membrane pixels. 
MOP-Induced ERK1/ERK2 Activation
Surface Plasmon Resonance Measurements
Gold substrates were prepared and surface plasmon resonance (SPR) experiments were conducted as previously described (Cuerrier et al., 2008; Maltais et al., 2012) . The HEK FlagMOP cells were grown to confluence on a gold substrate surface precoated with a solution of 5 mg/ml fibronectin (Sigma-Aldrich) and 200 mg/ml gelatin (BD, Franklin Lakes, NJ). Prior to stimulation, the cells were starved for 30 minutes with DMEM and stabilized in a HEPES-buffered salt solution (pH 7.4) containing 20 mM HEPES, 120 mM NaCl, 5.3 mM KCl, 1.8 mM CaCl 2 , 0.8 mM MgSO 4 and 11.1 mM dextrose for 30 minutes at 37°C. The pharmacological inhibitors presented above were used in SPR experiments to evaluate the contribution of their targeted signaling components in the SPR signatures obtained for DAMGO and morphine. In addition, epidermal growth factor (EGF) was used to confirm the viability of the cells after a 20-hour incubation in the presence of PTX. SPR data were analyzed with MatLab R2009a software (The MathWorks, Natick, MA) and smoothed using a moving average filter to allow maximal slope evaluation.
Phase-Contrast Microscopy
HEK FlagMOP cells were grown to confluence in 35-mm Petri dishes. Prior to the assay, the cells were starved in DMEM for 30 minutes and stabilized in HEPES-buffered salt solution during 30 minutes. Two minutes of baseline recording were performed before the incubation of the cells with 10 mM of each antagonist. The images were obtained with the 10Â objective of an Axio Observer Z1 microscope equipped with an Axio MRm camera (Carl Zeiss Canada, North York, Canada) at intervals of 10 seconds for 30 minutes at 37°C.
Bioluminescence Resonance Energy Transfer Experiments
DNA Constructs. The plasmid encoding green fluorescent protein (GFP) fused at the amino-terminus of human Gg2 was obtained by subcloning the human Gg2 coding sequence into GFP vectors (Galés et al., 2005) . The recombinant plasmid encoding for human Ga i1 -Luc91 was prepared using a flexible linker to insert the coding sequence of humanized Renilla luciferase (RLuc; PerkinElmer Life Sciences, Waltham, MA) into that of human Ga i1 between residues Leu91 and Lys92. Mouse MOP DNA in pCDNA3.1/Zeo was kindly provided by Dr. Alain Beaudet (McGill University, Montreal, Canada).
Cell Culture and Transfection. For bioluminescence resonance energy transfer (BRET) assays, HEK-293 cells were seeded at a density of 3.5 Â 10 6 cells in 100-mm Petri dishes, cultured for 24 hours, and transiently transfected with Gb 1 (3 mg), mouse MOP (8 mg), GFP-Gg 2 (3 mg), and Ga i1 -Luc91 (0.6 mg) (values for 100-mm Petri dishes) using polyethylenimine as indicated by the manufacturer. Experiments were carried out 48 hours after transfection. Cells were grown and maintained in DMEM supplemented with 10% fetal bovine serum, 2 mM L-glutamine, and 100 U/ml penicillin-streptomycin at 37°C in humidified atmosphere at 95% air and 5% CO 2 .
Monitoring Conformational Changes within the Gabg Heterotrimer. The way in which different MOP ligands modified Ga i interaction with the Gbg dimer was assessed using a methodology that we previously developed and validated for detection of ligandinduced conformational changes within GPCR signaling complexes (Audet et al., 2008 . Forty-eight hours after transfection, cells were washed twice and mechanically detached at room temperature with PBS, centrifuged for 5 minutes at 300 Â g (25°C), resuspended in PBS, and then distributed into a 96-well microplate (white Optiplate; PerkinElmer Life Sciences) at a concentration of 0.7 mg protein/ml. This concentration allowed us to achieve luminescence levels suitable for BRET readings. Cells were then incubated for 5 minutes with DeepBlueC coelenterazine (PerkinElmer Life Sciences), which was manually added into each well to a final concentration of 5 mM before the addition of different ligands at increasing concentrations as indicated. BRET2 readings were taken 5 minutes after ligand introduction. The BRET2 signal generated by each sample was determined by calculating the ratio of the light emitted by GFP (500-530 nm) over the light emitted by RLuc (370-450 nm) (Audet et al., 2008) .
Results
Agonist-Induced Internalization of MOP
In contrast with other MOP agonists, morphine was shown to induce minimal internalization of MOP in most cell types (Keith et al., 1998) . We first performed immunofluorescence labeling of FlagMOP in HEK FlagMOP cells submitted to various treatments (Fig. 1, A-E) . The micrographs are also presented using pseudo-colors to attribute each fluorescent pixel to either the cytosol (green) or the cell membrane (purple) (Fig. 1 , A9-E9). Under baseline conditions, the fluorescent labeling of FlagMOP was found to be located both at the plasma membrane and in the cytoplasm (Fig. 1 , A and A9). For these cells, the ratio of intracellular/plasma membrane fluorescent pixels is 1.02 6 0.07 (Fig. 1F ). When cells were treated with 1 mM morphine for 30 minutes (Fig. 1 , B and B9), the ratio of intracellular/plasma membrane labeling was not significantly changed compared with the control cells (2.12 6 0.21 versus 1.02 6 0.07; Fig. 1F ). By contrast, a 30-minute treatment with 1 mM DAMGO induced a robust internalization of MOP. In the DAMGO-treated cells, the MOP-like immunostaining was found almost exclusively inside the cells, with only discrete fluorescent puncta located at the cell membrane (Fig. 1, D and D9 ). Quantitatively, this treatment led to a 5-fold increase in the ratio of intracellular/plasma membrane pixels (5.15 6 0.53) compared with the control cells (Fig. 1F) . The inhibition of dynamin after pretreatment with 80 mM dynasore reversed both morphine-and DAMGO-induced increase of the intracellular/cell membrane labeling ratio of MOP (Fig. 1, C, C9 , E, E9, and F).
ERK1/ERK2 Activation
ERK1/ERK2 kinases are well known downstream effectors of MOP (Al-Hasani and Bruchas, 2011) . As shown in Fig. 2 , a 3-minute treatment with either morphine (Fig. 2A) or DAMGO (Fig. 2B ) induced concentration-dependent phosphorylation of ERK1/ERK2. Pretreatment with 10 mM CTAP, a selective MOP antagonist, confirmed that this effect was mediated by MOP activation. As shown in Fig. 3 , morphine and DAMGO also induced a similar time-dependent phosphorylation of ERK1/ERK2. For both agonists, the maximum level of phosphorylation was reached after 3 minutes of stimulation, with a return to baseline values 30 minutes after the application of the agonist.
To further characterize the signaling events involved in the MOP-induced activation of ERK1/ERK2, we performed experiments in which the cells were pretreated with various pharmacological inhibitors. We found that the pretreatment with 80 mM dynasore significantly inhibited the DAMGOinduced phosphorylation of ERK1/ERK2 (Fig. 4A ). Although these results were not statistically significant, a trend was observed, suggesting that the morphine-induced activation of ERK1/ERK2 also involves dynamin. As shown in Fig. 4B , PTX (inhibitor of Ga i ) completely blocked the morphine-and DAMGO-induced phosphorylation of ERK1/ERK2, whereas CTX (activator of Ga s ) had no significant effect (Fig. 4B) . Finally, we performed a concentration-response evaluation of U0126 efficacy and we found that this MEK inhibitor is ineffective when used at submicromolar concentrations. Indeed, we found that 2 mM was the lowest effective concentration (i.e., the lowest concentration able to inhibit the agonist-induced activation of ERK1/ERK2) (Fig. 4C) .
SPR Measurements
Next, SPR was used to assess the global cellular response resulting from the stimulation of MOP with DAMGO and morphine. We first performed SPR experiments with increasing concentrations (from 1 nM to 1 mM) of the agonists. As shown in Fig. 5A , morphine induced a concentrationdependent SPR signal. The signal was characterized by a fast increase of the reflectance value followed by a slower decrease within the next few minutes. The signal reached a plateau at approximately 30 minutes at each concentration. As reported in Table 1 , the maximal amplitude of the SPR signal of morphine peaked at 100 nM, whereas the maximal initial slope was obtained at 10 nM. Similar results were obtained when the cells were incubated with increasing concentrations of DAMGO ( Fig. 5B ; Table 1 ). For both agonists, the signal was blocked by a pretreatment with 10 mM CTOP (D-Phe-CysTyr-D-Trp-Orn-Thr-Pen-Thr-NH 2 ). Note that the injection of 10 mM CTOP (represented by the pound symbol in Fig. 5 ) induced a weak SPR signal, whereas the vehicle (represented by the plus symbol in Fig. 5 ) did not induce any detectable SPR signal other than the injection peak. SPR measurements on HEK-Mock cells (i.e., cells transfected with an empty construct) were also performed to eliminate a possible offtarget effect of both MOP agonists. As expected, neither 100 nM morphine nor 100 nM DAMGO produced a detectable response (results not shown). 
Surface Plasmon Resonance to Assess Signaling Cascades
Pharmacological inhibitors were used to evaluate the contribution of different signaling pathways in the generation of the SPR signals induced by morphine and DAMGO. First, we investigated the implication of MOP internalization using dynasore. Because the pretreatment was conducted outside of the SPR system, we validated that dynasore had no effect on the integrity of the cell monolayer or on the cellular membrane by analyzing the SPR angular scans with or without pretreatment. This analysis revealed that dynasore had no effect on the SPR resonance angle (72.97°6 0.07°v ersus 72.83°6 0.07°, with and without pretreatment respectively; P . 0.05, unpaired t test), suggesting that it did not affect the integrity of the cells. As shown in Fig. 6 and reported in Table 2 , the pretreatment with dynasore produced a limited but significant decrease in the SPR signal amplitude after morphine and DAMGO treatments. Conversely, the maximal initial slope was not affected by this inhibitor (Table 2) . Second, we studied the implication of G proteins using CTX and PTX. We observed that in the presence of PTX, morphine and DAMGO failed at producing any SPR signal (Fig. 7, A and B) . Interestingly, although CTX had no effect on the morphine-and DAMGO-induced phosphorylation of ERK1/ERK2 (see Fig. 4A ), it induced a significant decrease in the amplitude of the SPR signals induced by morphine and DAMGO (Fig. 7, A and B ; Table 2 ). In addition, CTX had a significant effect on the maximal initial slope of the SPR response of morphine but not DAMGO ( Table 2 ). Note that pretreatments with the toxins are not shown on their respective SPR traces because they were done 20 hours before the experiments and were therefore conducted outside of the SPR chamber. As shown in Fig. 7 , C and D, the MEK inhibitor U0126, which had no effect by itself on the SPR signal other than an injection peak (pound symbol), also significantly altered the amplitude of the SPR signal induced both by morphine and DAMGO, and the maximal initial slopes of both SPR responses were not significantly different ( Table 2) .
As mentioned above, an SPR signal profile, different from what is usually observed with vehicle, was detected after the addition of CTOP to the cells (see Fig. 5 ). To further characterize this unexpected antagonist-induced SPR response, we extended our study by evaluating CTOP and three other MOP antagonists (naltrexone, naloxone, and CTAP). As shown in Fig. 8, A-D , all four antagonists generated notable SPR responses when used at a concentration of 10 mM on the HEK FlagMOP cells. Despite the fact that the amplitudes of the SPR signals induced by the antagonists are less important Concentration-dependent effect of morphine (A) and DAMGO (B). Both morphine and DAMGO induced a concentration-dependent activation of ERK1/ERK2, respectively, reaching a peak at a concentration of 1 mM and 100 nM. This effect is blocked by a pretreatment with 10 mM CTAP. The results of the densitometric analysis are reported in the histograms. *P , 0.05 (one-way ANOVA with a Dunnett's post hoc test). The error bars indicate S.E.M. than those triggered by morphine and DAMGO, the SPR signal profiles for naltrexone, naloxone, and CTOP were very similar (compare Fig. 8, A , B, and D, with Fig. 5 ). The signal produced by CTAP is markedly different (Fig. 8C ) compared with the other antagonists. As opposed to other conditions tested in this study, CTAP led to a decrease in the reflectance value. To determine whether the signals generated by the antagonists were Ga i/o mediated, we repeated these (B) Implication of Ga i and Ga s in morphine-and DAMGO-induced activation of ERK1/ERK2. The pretreatment with PTX completely blocked the activation of ERK by both agonists, whereas the pretreatment with CTX had no effect. (C) Concentration-response evaluation of U0126 efficacy. The pretreatment with U0126 is ineffective in the submicromolar concentrations, whereas ERK1/ERK2 phosphorylation is completely blunted when U0126 is used at 2 mM. The results of the densitometric analysis are reported in the histograms. *P , 0.05; **P , 0.01; ***P , 0.001 (one-way ANOVA with a Bonferroni's post hoc test). The error bars indicate S.E.M. Surface Plasmon Resonance to Assess Signaling Cascades experiments in cells preincubated with PTX and found that the SPR responses triggered by all antagonists were abolished by PTX (Fig. 8, A-D) . As shown in Fig. 8E , phase-contrast microscopy revealed that the stimulation with 10 mM naltrexone induced a spreading of the cells on the surface, correlating the increase of the reflectance observed in the SPR signal. This is exemplified by a decrease of the intercellular spaces (Fig. 8E, white arrows) . Conversely, stimulation with 10 mM CTAP had the opposite effect. CTAP induced a contraction of the cells accompanied by an enlargement of the intercellular spaces (Fig. 8F, white arrows) , which correlates with a decrease in the reflectance observed in the SPR signal. The absence of potential off-target effects of the antagonists was confirmed by SPR measurements on HEKMock cells (results not shown). To assess the viability of the cells treated with PTX, we measured their ability to respond to EGF, a tyrosine kinase receptor agonist. As shown in Fig. 9 , a 20-hour treatment with PTX did not significantly affect the SPR response triggered by EGF.
BRET Experiments
A considerable proportion of ligand-induced SPR responses were PTX sensitive, suggesting that reflectance changes by agonists and antagonists all required functional Ga i/o proteins. We previously used BRET-based biosensors to show that occupation of d-opioid receptors by ligands of different efficacies all induced significant but distinct conformational rearrangements among heterotrimeric Gabg subunits (Audet et al., 2008) . Thus, it was of interest to determine whether MOP ligands that modified the basal SPR signal were also able to perturb in any way the interaction among Gabg subunits. To answer this question, we used BRET-based biosensors that monitor small conformational changes at the interface of the Ga subunit and Gbg dimer (Audet et al., 2008) . In particular, the donor was Ga i1 tagged with RLuc at position 91 of the helical domain and the acceptor was Gg 2 bearing GFP at the amino-terminus (see Fig. 10B ). Consistent with SPR data and with the notion that MOP ligands of different efficacies induce conformational changes among heterotrimeric subunits, DAMGO, naltrexone, and CTAP all induced concentration-dependent decreases in basal energy transfer. Furthermore, BRET changes induced by the agonist DAMGO were greater than those induced by naltrexone and CTAP, which in turn did not differ from one another (Fig.  10A) .
Discussion
This study aimed to assess downstream signaling cascades of the MOP in live cells using the label-free approach SPR spectroscopy. Our hypothesis was that different ligands acting on MOP would generate distinct SPR signatures due to the selective activation of the downstream signaling cascades. The contribution of three important components of MOP signaling (internalization of the receptor, G protein coupling, and ERK1/ERK2 activation) was investigated on the SPR signals triggered by multiple ligands. 1 5 0 6 4 3 0 6 2 4 1 6 2 3 2 6 2 10 99 6 6* 87 6 7*** 65 6 4* 62 6 5*** 100 137 6 11*** 131 6 8*** 58 6 4 6 4 6 4*** 1000 118 6 12*** 116 6 10*** 54 6 8 5 8 6 6**
The signal amplitude and initial slope were calculated for the SPR signals obtained after stimulation with increasing concentrations of morphine and DAMGO. RVU is an arbitrary unit (1 RVU = 0.001 unit of reflectance). The results are reported as the mean 6 S.E.M (n = 5 to 6). *P , 0.05; **P , 0.01; ***P , 0.001 (one-way ANOVA followed by a Bonferroni's post hoc test, compared with 1 nM results). SPR spectroscopy is based on the quantification of discrete variations of molecular density (i.e., refractive index) within the evanescent field created at the surface of a thin gold layer on which the cells are cultured. Because the plasma membrane of cultured cells is largely confined in the evanescent field, minute changes in mass distribution (e.g., addition/retrieval of proteins) at or in the vicinity of the plasma membrane affect the integrated SPR signal (Fang et al., 2006) .
In this study, analysis of the SPR signals triggered by increasing concentrations of morphine and DAMGO revealed an initial slope that peaked at 10 nM, whereas the maximal amplitude of the signal was reached at 100 nM. The reasons why the maximal slope and amplitude were not reached at the same concentrations are not clear. However, we hypothesize that the slope of the SPR signal represents the rate of activation of the cellular processes, likely dependent on the rate of receptor occupation, whereas the maximal amplitude of the signal is reached at saturating concentrations (i.e., when receptor occupation is maximal).
Because receptor internalization includes the removal of cell surface proteins and phospholipids, we expected that internalizing and noninternalizing agonists would produce distinct SPR signatures. In transfected cells, most MOP agonists except morphine are known to induce a rapid internalization of the receptor (Keith et al., 1998) . In this study, we observed that morphine elicited a limited, dynasoresensitive increase in the intracellular/cell membrane pixel ratio over the control. We also confirmed that DAMGO induced a robust internalization of MOP. Surprisingly, the SPR analyses failed to reveal any difference between the signals triggered by morphine and DAMGO. It is likely that the negative contribution of internalization is masked by cellular processes occurring simultaneously but contributing positively to the signal, such as an increased cell adhesion. Similar conclusions have been drawn for b2 adrenergic receptor agonists (Fang and Ferrie, 2008) . On the other hand, we observed that inhibition of dynamin affects both morphineand DAMGO-induced ERK1/ERK2 activation and SPR responses. Considering that DAMGO and morphine displayed different receptor internalization profiles but that their signaling properties were still inhibited to a similar extent by dynasore, our results suggest that dynamin may have an The signal amplitude and slope were calculated for the SPR signals obtained after a stimulation with 100 nM agonist with indicated pretreatments. RVU is an arbitrary unit (1 RVU = 0.001 unit of reflectance). The results are reported as the mean 6 S.E.M (n = 5 to 6). *P , 0.05; **P , 0.01; ***P , 0.001 (one-way ANOVA followed by a Dunnett's post hoc test, compared with control results). Surface Plasmon Resonance to Assess Signaling Cascades internalization-independent role in MOP-mediated signaling, as previously suggested by others (Whistler and von Zastrow, 1999) . Although the precise mechanisms linking dynamin to MOP's downstream signaling cascades remain to be identified, the actin cytoskeleton and proteins interacting with dynamin are putative candidates (Ferguson and De Camilli, 2012) .
In an effort to distinguish the responses triggered by morphine and DAMGO, we have also monitored the ERK1/ ERK2 signaling cascade and its contribution to the SPR signals. Our results revealed that the inhibition of ERK1/ ERK2 with U0126, a potent MEK inhibitor, significantly reduced the maximal amplitude of the SPR responses induced by both MOP agonists. Other groups previously showed that the maximal responses triggered by morphine and DAMGO were barely affected by U0126 (Codd et al., 2011; Morse et al., 2011) . Although Epic (Morse et al., 2011) and SPR (current study) are dynamic mass redistribution optical biosensors, their detecting systems are slightly different. Therefore, the difference observed is likely due to the ability/sensitivity of the systems to detect specific cellular events.
Over the years, several GPCRs were analyzed using opticaland impedance-based biosensors . Among them, the Ga i -coupled muscarinic type 2 receptor was studied on both platforms. Interestingly, the signal produced upon the activation of the Ga i -coupled muscarinic type 2 receptor by an agonist is similar to the signals we observed after the activation of MOP. Here, we found that the inhibition of Ga i with PTX abolished agonist-induced phosphorylation of ERK1/ERK2, as well as the typical SPR signal. The PTX sensitivity of MOP-mediated ERK1/ERK2 activation is not novel (Li and Chang, 1996; Belcheva et al., 1998) . However, the fact that PTX totally abolished the SPR responses is puzzling. One could argue that an overnight PTX treatment of HEK cells could have affected their viability/integrity. However, we demonstrated that this was not the case because with and without pretreatment with 100 ng/ml PTX. (E and F) Phase-contrast microscopy assays performed with naltrexone and CTAP, respectively. Correlation between SPR measurements and phase-contrast microscopy assays can be made using roman numerals indicated by dark arrows in (A) and (C) and at the top right of (E) and (F). All of these MOP antagonists generated detectable SPR signals and these signals were blocked with a pretreatment with PTX. These responses are correlated with changes in cell morphology because naltrexone induced a spreading and CTAP, a contraction. Addition of + vehicle or *antagonist.
PTX failed to abolish the SPR signature induced by the activation of the EGF receptor (Fig. 9) , confirming that Ga i signaling is essential to initiate the MOP-mediated signaling cascades measured by SPR.
We found that the treatment of HEK FlagMOP cells with CTX had no effect on morphine-and DAMGO-induced ERK1/ ERK2 phosphorylation. Surprisingly, CTX significantly modified the SPR signatures of both MOP agonists. CTX treatment is known to elicit an increase in intracellular cAMP levels (Guerrant et al., 1974) . cAMP binds and activates numerous proteins involved in various cellular processes, including the regulation of cell morphology. Morse et al. (2011) also found that a CTX treatment induces a decrease in the Epic signals generated by some MOP agonists and suggested an implication of Ga s . The direct implication of Ga s in generating the morphine-and DAMGO-mediated SPR signals is unlikely, although it cannot be entirely ruled out. Indeed, because it has been shown that label-free biosensors can reveal dual G protein signaling ), any Ga s -mediated effect would have been observed in the presence of PTX. Together, our observations suggest that the agonist-induced SPR responses are influenced by cAMP levels, possibly by affecting cell morphology.
One of the most intriguing findings of this study is the SPR responses induced by MOP antagonists. Our phase-contrast microscopy analysis revealed that these SPR signals are correlated with changes in cell morphology. Considering similarities with SPR signals induced by morphine and DAMGO, one possible interpretation is that the smaller, PTX-sensitive SPR changes induced by naltrexone, naloxone, and CTOP reveal partial agonist properties rather than neutral antagonists. Indeed, previous studies in heterologous systems expressing MOPs indicate that naloxone inhibits cAMP production in a PTX-dependent manner (Fukuda et al., 1998) . Moreover, our experiments assessing energy transfer at the Ga-bg interface revealed that naltrexone induced a concentration-dependent decrease in BRET (see Fig. 10A ). A decrease in BRET at this interface is consistent with recent crystallographic evidence indicating that activation of the G protein by an agonist-occupied receptor is associated with displacement of the helical domain of the Ga subunit away from the free terminal ends of Gb-and Gg-subunits (Rasmussen et al., 2011) . Interestingly, the SPR signature triggered by CTAP differs from all other responses described , and CTAP (square). Dose-response curves were compared by two-way ANOVA, which indicated an effect of drug (P , 0.001), an effect of concentration (P , 0.001), and an interaction (P , 0.001; n = 5 to 6). Further analysis indicated that dose-response curves by naltrexone and CTAP differed from DAMGO (P , 0.001) but not among each other. (B) Schematic representation of the putative conformational changes induced by different ligands at the Ga-bg interface as assessed by the Gai1-Luc91/GFP-Gg2 BRET biosensor. The ligand-free receptor is predominantly inactive as is the G protein. In this situation, the donor BRET tag on the helical domain of Gai1 (RLuc, represented in blue) and the acceptor tag on the N terminus of Gg2 (GFP, represented in green) are close to one another generating measurable basal energy transfer. Binding of a full agonist produces a large decrease in BRET, which is consistent with a large displacement of the Ga helical domain away from the Gg2 tag. Binding of partial agonist produces a smaller displacement. Being efficacious agonists, displacements by both ligands are expected to induce GDP-GTP nucleotide exchange, although reduced displacement of BRET tags by the partial agonist would suggest a more restricted exchange than for the full agonist. Binding of an inverse agonist also induces conformational changes that separate donor-acceptor tags at the Ga-bg interface, but this rearrangement would lock the G protein in a conformation that does not allow nucleotide exchange. The topography of Gabg trimer and its interaction with the receptor were represented as in Rasmussen et al. (2011) .
Surface Plasmon Resonance to Assess Signaling Cascades in this study. Indeed, CTAP induced a decrease in reflectance, whereas all other tested MOP ligands produced an increase. Based on the SPR signals, CTAP therefore behaves as an inverse MOP agonist. In support of our findings, CTAP was previously described as an inverse agonist (Divin et al., 2009) . Surprisingly, we observed no difference between the BRET responses induced by CTAP and naltrexone. We previously observed that d-opioid receptor partial and inverse agonists could similarly modify energy transfer at one vantage point, but the overall conformational rearrangement at the Ga-bg interface was still different when observed from other ones within the Ga subunit (Audet et al., 2008) . A graphic representation of possible conformational changes imposed on the Ga-bg interface by ligands of different efficacies is shown in Fig. 10B . The implication of Ga i in the signaling of CTAP is therefore most likely the consequence of the constitutive activity of MOP (Burford et al., 2000) . In the presence of PTX, the constitutive activation of Ga i is abolished (Seifert and Wenzel-Seifert, 2002) , which, by way of consequence, impairs the ability of CTAP to elicit a biologic response. Accordingly, we found that the SPR response induced by CTAP was blunted in the presence of PTX. Finally, it is worth noting that a SPR response was observed with concentrations of agonists as low as 1 nM, whereas no difference in the BRET signal was observed until 10-to 100-fold concentrations were used (compare Fig. 10A with Fig. 5B and Fig. 8, A and C) . We previously showed that the BRET signals produced by G protein BRET biosensors after opioid stimulations reached a steady-state after 2 minutes RichardLalonde et al., 2013) . Since we performed the BRET2 readings 5 minutes after the addition of the ligands, which also corresponds to the maximal SPR response, SPR appears to be more sensitive in detecting signaling events occurring after ligand binding and receptor activation than BRET2 biosensor. Interestingly, our SPR results also revealed that the relation between agonist concentration and the maximal reflectance is biphasic, whereas a monophasic response was observed in the BRET experiments. This may be explained by the fact that BRET experiments are designed to detect a single parameter (i.e., conformational changes within the Ga i heteromer), whereas the purpose of SPR is to evaluate the integrated cell response.
Based on previous studies from our group (Cuerrier et al., 2008; Simard et al., 2013) , we propose that an important contribution to the SPR signal after stimulation with MOP agonists, as well as MOP so-called antagonists, could be due to a Ga i -and ERK1/ERK2-dependent actin cytoskeleton rearrangement. Accordingly, our results revealed an important role of ERK1/ERK2 and Ga i in the generation of the SPR signal evoked by the activation of MOP. In conclusion, our findings show that SPR spectroscopy is highly effective and sensitive in monitoring the integrated cell signaling upon stimulation of GPCRs, which could also represent a technical asset to address functional selectivity.
